A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale

✍ Scribed by Rajendra H. Mehta; John H. Alexander; Robert Emery; Stephen J. Ellis; Vic Hasselblad; Ahmad Khalil; Michel Carrier; Robert A. Harrington; Jean-Claude Tardif

• Book ID: 116191332
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 209 KB
• Volume: 155
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2008.01.002